
Brian E. Mcdowell
Examiner (ID: 2181, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1622 |
| Issued Applications | 1025 |
| Pending Applications | 135 |
| Abandoned Applications | 522 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12239873
[patent_doc_number] => 20180072737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'CO-CRYSTALS OF IBRUTINIB WITH CARBOXYLIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 15/559410
[patent_app_country] => US
[patent_app_date] => 2016-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8741
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559410
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/559410 | Co-crystals of ibrutinib with carboxylic acids | Mar 22, 2016 | Issued |
Array
(
[id] => 12233088
[patent_doc_number] => 20180065951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'Formylated N-heterocyclic derivatives as FGFR4 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/561189
[patent_app_country] => US
[patent_app_date] => 2016-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42904
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15561189
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/561189 | Formylated N-heterocyclic derivatives as FGFR4 inhibitors | Mar 22, 2016 | Issued |
Array
(
[id] => 12185407
[patent_doc_number] => 20180044343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'BICYCLIC IMIDAZOLO DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 15/557580
[patent_app_country] => US
[patent_app_date] => 2016-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 61147
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15557580
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/557580 | BICYCLIC IMIDAZOLO DERIVATIVE | Mar 14, 2016 | Abandoned |
Array
(
[id] => 16414469
[patent_doc_number] => 10822345
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-03
[patent_title] => KV1.3 inhibitors and their medical application
[patent_app_type] => utility
[patent_app_number] => 15/557696
[patent_app_country] => US
[patent_app_date] => 2016-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25392
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15557696
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/557696 | KV1.3 inhibitors and their medical application | Mar 13, 2016 | Issued |
Array
(
[id] => 11122156
[patent_doc_number] => 20160319130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'NOVEL COMPOUND, PHOTOSENSITIVE RESIN COMPOSITION FOR COLOR FILTER COMPRISING THE SAME AND COLOR FILTER'
[patent_app_type] => utility
[patent_app_number] => 15/068791
[patent_app_country] => US
[patent_app_date] => 2016-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4761
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15068791
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/068791 | NOVEL COMPOUND, PHOTOSENSITIVE RESIN COMPOSITION FOR COLOR FILTER COMPRISING THE SAME AND COLOR FILTER | Mar 13, 2016 | Abandoned |
Array
(
[id] => 12205802
[patent_doc_number] => 20180051029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'PYRROLOPYRIDAZINE INHIBITORS OF IRAK4 ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/557201
[patent_app_country] => US
[patent_app_date] => 2016-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27808
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15557201
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/557201 | Pyrrolopyridazine inhibitors of IRAK4 activity | Mar 6, 2016 | Issued |
Array
(
[id] => 12185359
[patent_doc_number] => 20180044295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'COMPOUNDS FOR MODULATING MITOCHONDRIAL FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 15/554767
[patent_app_country] => US
[patent_app_date] => 2016-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 17320
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15554767
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/554767 | Compounds for modulating mitochondrial function | Mar 2, 2016 | Issued |
Array
(
[id] => 16756540
[patent_doc_number] => 10975076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Compositions, uses and methods for making them
[patent_app_type] => utility
[patent_app_number] => 15/555024
[patent_app_country] => US
[patent_app_date] => 2016-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24690
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555024
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/555024 | Compositions, uses and methods for making them | Mar 1, 2016 | Issued |
Array
(
[id] => 11735990
[patent_doc_number] => 09700559
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-11
[patent_title] => 'Compounds and compositions for the treatment of parasitic diseases'
[patent_app_type] => utility
[patent_app_number] => 15/051446
[patent_app_country] => US
[patent_app_date] => 2016-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 47568
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15051446
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/051446 | Compounds and compositions for the treatment of parasitic diseases | Feb 22, 2016 | Issued |
Array
(
[id] => 11880715
[patent_doc_number] => 09751873
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-05
[patent_title] => 'Aryl sultam derivatives as RORc modulators'
[patent_app_type] => utility
[patent_app_number] => 15/047523
[patent_app_country] => US
[patent_app_date] => 2016-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54154
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047523
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/047523 | Aryl sultam derivatives as RORc modulators | Feb 17, 2016 | Issued |
Array
(
[id] => 12151511
[patent_doc_number] => 20180022760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'CONDENSED HETEROCYCLIC COMPOUNDS AND PESTICIDES'
[patent_app_type] => utility
[patent_app_number] => 15/550165
[patent_app_country] => US
[patent_app_date] => 2016-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 183196
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550165
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550165 | Condensed heterocyclic compounds and pesticides | Feb 11, 2016 | Issued |
Array
(
[id] => 11908215
[patent_doc_number] => 09777019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use'
[patent_app_type] => utility
[patent_app_number] => 15/041835
[patent_app_country] => US
[patent_app_date] => 2016-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70243
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15041835
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/041835 | Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use | Feb 10, 2016 | Issued |
Array
(
[id] => 12178804
[patent_doc_number] => 20180037740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'PHTHALOCYANINE-BASED COMPLEX COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 15/551288
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11615
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15551288
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/551288 | PHTHALOCYANINE-BASED COMPLEX COMPOUND | Feb 8, 2016 | Abandoned |
Array
(
[id] => 10805206
[patent_doc_number] => 20160151363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Cadherin-11 Inhibitors and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/017040
[patent_app_country] => US
[patent_app_date] => 2016-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 18925
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15017040
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/017040 | Cadherin-11 inhibitors and methods of use thereof | Feb 4, 2016 | Issued |
Array
(
[id] => 12138188
[patent_doc_number] => 20180016271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'FLUORINATED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS INHIBITORS OF BROMODOMAIN CONTAINING PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/546324
[patent_app_country] => US
[patent_app_date] => 2016-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 35095
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15546324
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/546324 | Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins | Feb 2, 2016 | Issued |
Array
(
[id] => 11704508
[patent_doc_number] => 20170173007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'PYRIDAZINONE COMPOUNDS AND THEIR USE AS DAAO INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/014336
[patent_app_country] => US
[patent_app_date] => 2016-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30098
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15014336
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/014336 | Pyridazinone compounds and their use as DAAO inhibitors | Feb 2, 2016 | Issued |
Array
(
[id] => 13278403
[patent_doc_number] => 10150773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-11
[patent_title] => N-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6- dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (SGC) for the treatment of cardiovascular diseases
[patent_app_type] => utility
[patent_app_number] => 15/548310
[patent_app_country] => US
[patent_app_date] => 2016-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15472
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548310
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548310 | N-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6- dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (SGC) for the treatment of cardiovascular diseases | Feb 1, 2016 | Issued |
Array
(
[id] => 15355445
[patent_doc_number] => 10526323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
[patent_app_type] => utility
[patent_app_number] => 15/547781
[patent_app_country] => US
[patent_app_date] => 2016-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33915
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547781
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/547781 | Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | Jan 31, 2016 | Issued |
Array
(
[id] => 12790405
[patent_doc_number] => 20180155304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => CATIONIC LIPID
[patent_app_type] => utility
[patent_app_number] => 15/547317
[patent_app_country] => US
[patent_app_date] => 2016-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12294
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547317
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/547317 | Cationic lipid | Jan 28, 2016 | Issued |
Array
(
[id] => 16215092
[patent_doc_number] => 10730890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-04
[patent_title] => Phthalocyanine derivative consisting of a mixture of 4 isomers
[patent_app_type] => utility
[patent_app_number] => 15/008875
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 4846
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15008875
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/008875 | Phthalocyanine derivative consisting of a mixture of 4 isomers | Jan 27, 2016 | Issued |